We already know that – compared to the general population –osteoporosis (problems due to weak bones) is more common both among people living with HIV and among people living with hepatitis C (HCV). There is a link between the viruses and bone loss, possibly caused by the immune system’s ongoing inflammation and activation, as it attempts to deal with the infections. In addition, the damage hepatitis C does to the liver has an impact on the bones. There may also be a link between the anti-HIV drug tenofovir (Viread, also in the combination pills Truvada, Atripla, Eviplera and Stribild) and bone problems.
A new study shows that the risk of osteoporosis is greater for people co-infected with HIV and HCV than for those with only one of those viruses.
The full article can be read here.